Drug Formulary Review Archives – September 1, 2003
September 1, 2003
View Archives Issues
-
ASHP moves into the next phase of its 2015 Initiative
The future of pharmacy practice has become a focus for one pharmacy group, and the reaction from members has been favorable and enthusiastic. -
Goals of the 2015 Initiative
The American Society of Health-System Pharma-cists (ASHP) in Bethesda, MD, released in May a draft of the goals and objectives for pharmacy practice in health systems to be achieved by 2015. -
Clinical judgment, standard of care is key
Off-label use of a drug is common in health care, but pharmacists agree that they must minimize the risk by relying on their clinical judgment and the standard of care. -
FDA turns up heat on drug counterfeiters
The U.S. Food and Drug Administration (FDA) has announced a new initiative to fight drug counterfeiters. As part of the initiative, an internal task force will look into technology and other measures including better education of pharmacists to try to stop counterfeit drugs from being distributed with or deliberately substituted for safe and effective drugs. -
New FDA Approvals
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA): -
News Briefs
Pharmacist shortage continues despite lower vacancies; Scholarship campaign launched to recruit pharmacy teachers; Warnings added to topiramate and somatropin; ASHP speaks out againstmarket access bill -
Drug Criteria & Outcomes
Zoledronic acid (Zometa) drug evaluation